During my coverage of SXSW Online 2022, I caught the featured session “Psychedelics for Therapeutics and Well-being.” This session explored how modern research in psychedelics has shifted from the Timothy Leary “turn-on, tune-in, and drop-out” culture that defined the ’60s into an evidence-based treatment for psychiatric diseases.



How Psychedelics Can Alleviate Human Suffering

Roland Griffiths, Psychopharmacologist at the Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, offered a concise summary of the current state of psychedelics research. “I’m fond of saying that we know a lot that we didn’t know in the past 15 years. But we’re also astonishingly ignorant about basically what’s going on here.” The signal that seems to be the strongest regarding psilocybin research is in addressing treatment resistant depression. Also, there’s been some recent studies exploring the use of psilocybin in treating addictions to substances such as cigarettes, cocaine, and alcohol. For a deeper dive into Dr. Griffiths’ research on psychedelics and mental illness, check out his website.

Source link